Canon Medical System, USA, INC. recalls VANTAGE GALAN 3T. CMSC Model: MRT-3020/U7
Model Number: MEXL-3020/B7. beginning October 16, 2025, in a medical device recall whose distribution included Ohio.
Canon Medical System, USA, INC. began a medical device recall on October 16, 2025 whose reported distribution included Ohio. FDA
What the record shows
recalled VANTAGE GALAN 3T. CMSC Model: MRT-3020/U7. Model Number: MEXL-3020/B7. beginning October 16, 2025, in a medical device recall whose distribution included Ohio. The stated reason: Affected system contains components that do not meet the required distance between electrodes for compliance with the IEC 60601-1 standard for medical electrical equipment. FDA graded it Class II — use may cause temporary or medically reversible health consequences. Quantity affected: 2 units. The recall is listed as ongoing. FDA
Context
By the numbers
- Date of record: October 16, 2025 FDA
- Recall number: Z-0327-2026 FDA
- Recalls in this action: 1 FDA
- Recalling firm: Canon Medical System, USA, INC. FDA
- Product: VANTAGE GALAN 3T. CMSC Model: MRT-3020/U7. Model Number: MEXL-3020/B7. FDA
- Reason for recall: Affected system contains components that do not meet the required distance between electrodes for compliance with the… FDA
Assembled mechanically from the source filing and The Lantern's own record database — no AI-written prose. Every figure above appears verbatim in the cited record, which is linked on this page. FDA
Sources
The source filing
| Recall number | Z-0327-2026 |
|---|---|
| Recalls in this action | 1 |
| Recalling firm | Canon Medical System, USA, INC. |
| Product | VANTAGE GALAN 3T. CMSC Model: MRT-3020/U7. Model Number: MEXL-3020/B7. |
| Reason for recall | Affected system contains components that do not meet the required distance between electrodes for compliance with the IEC 60601-1 standard for medical electrical equipment. |
| Classification | Class II — use may cause temporary or medically reversible health consequences |
| Recall type | medical device |
| Quantity | 2 units |
| Status | Ongoing |
| Voluntary or mandated | Voluntary: Firm initiated |
| Initiated | 20251016 |
| Reported | 20251105 |
| Distribution | US distribution to Ohio and Nevada |
| Firm location | Tustin, CA, United States |
Published by U.S. Food and Drug Administration (openFDA). This is the agency's public filing as The Lantern received it, shown with its fields named in plain English.